University of Massachusetts - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

University of Massachusetts - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Massachusetts - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
University of Massachusetts - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
38 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

University of Massachusetts (UMASS), formerly Massachusetts State College is a research university that offers graduate, undergraduate, summer courses, professional and distance learning programs. The university conducts research activities in areas of clinical and translational science, food science, other life sciences, environmental science, bioinformatics, marine science and bio-engineering, cell engineering, computer networking, nanotechnology, alternative energy, advanced materials and nanotech manufacturing.

University of Massachusetts - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company&ap

  
Source:
Document ID
GDPH71563D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
University of Massachusetts, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
University of Massachusetts, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
University of Massachusetts, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
University of Massachusetts, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
University of Massachusetts, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
University of Massachusetts, Pharmaceuticals &Healthcare, Deal Details1123
  Partnerships111
    Quad Technologies Partners with University of Massachusetts Medical School111
    Anika Therapeutics Enters into Research Agreement with University of Massachusetts Amherst121
    Lysogene Enters into Agreement with University of Massachusetts Medical School and Auburn University131
    UMass Enters Into An Agreement With UOT, Tampere Institute, VTT, University Of Ulster And Queen's University142
    University Of Massachusetts Forms Joint Venture With UK Stem Cell161
    Lundbeck Enters Into Collaboration With The University Of Massachusetts172
    BioServe Biotechnologies Enters Into Strategic Alliance With The University of Massachusetts Medical School191
    RXi Pharma Enters Into Co-Development Agreement With The UMMS201
  Licensing Agreements211
    ImmuCell Enters into Option Agreement with University of Massachusetts Amherst to License New Bacteriocin Technology211
    Amarantus Bioscience Enters Into Option For Licensing Agreement With University of Massachusetts221
    Voyager Therapeutics Enters into Licensing Agreement with University of Massachusetts232
    Amarantus Bioscience Enters Into Licensing Agreement With University of Massachusetts Medical School251
    University of Massachusetts Medical School Enters Into Licensing Agreement With Agalimmune For Alphaject262
    Silence Therapeutics Terminates Licensing Agreement With University Of Massachusetts281
    UMass Lowell Enters into Licensing Agreement with Sevo Nutraceuticals for Cognitive Function Nutritional Supplements291
    The University of Massachusetts Medical Enters Into Licensing Agreement With Merck302
  Asset Transactions321
    Quest Diagnostics Completes Acquisition Of Clinical Outreach Lab Business Of UMass Memorial Medical Center322
University of Massachusetts - Key Competitors341
Key Employees351
Locations And Subsidiaries362
  Head Office361
  Other Locations &Subsidiaries362
Appendix381
  Methodology381
  About GlobalData381
  Contact Us381
  Disclaimer381

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "University of Massachusetts - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Massachusetts-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7801>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). University of Massachusetts - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Massachusetts-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7801>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research